Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling

Hong Liu

doi:DOI: 10.2147/DDDT.S219533

Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling

Anesthesiology and Pain Medicine

Research output: Contribution to journal › Article

Original language	English (US)
Journal	Drug Design, Development and Therapy
DOIs	https://doi.org/DOI: 10.2147/DDDT.S219533
Publication status	Published - 2019

Cite this

Liu, H. (2019). Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling. Drug Design, Development and Therapy. https://doi.org/DOI: 10.2147/DDDT.S219533

@article{c0628abca1c545d0a4dd1189f80a9735,

title = "Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling",

author = "Hong Liu",

year = "2019",

doi = "DOI: 10.2147/DDDT.S219533",

language = "English (US)",

journal = "Drug Design, Development and Therapy",

issn = "1177-8881",

publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling

AU - Liu, Hong

PY - 2019

Y1 - 2019

U2 - DOI: 10.2147/DDDT.S219533

DO - DOI: 10.2147/DDDT.S219533

M3 - Article

JO - Drug Design, Development and Therapy

JF - Drug Design, Development and Therapy

SN - 1177-8881

ER -

Access to Document

DOI: 10.2147/DDDT.S219533